Single‐pill combination of cilnidipine, an l‐/n‐type calcium channel blocker, and valsartan reduces the day‐by‐day variability of morning home systolic blood pressure in patients with treated hypertension: A sub‐analysis of the HOPE‐combi survey

Lignende værker

• Single‐pill combination of cilnidipine, an L‐/N‐type calcium channel blocker, and valsartan effectively reduces home pulse pressure in patients with uncontrolled hypertension and sympathetic hyperactivity: The HOPE‐Combi survey
  af: Kario, Kazuomi, et al.
  Udgivet: (2020)
• Effects of Cilnidipine, an L/N-Type Calcium Channel Blocker, on Carotid Atherosclerosis in Japanese Post-Stroke Hypertensive Patients: Results from the CA-ATTEND Study
  af: Nezu, Tomohisa, et al.
  Udgivet: (2018)
• Comparative effects of valsartan plus cilnidipine or hydrochlorothiazide on nocturnal home blood pressure
  af: Fujiwara, Takeshi, et al.
  Udgivet: (2021)
• Comparative effects of valsartan plus either cilnidipine or hydrochlorothiazide on home morning blood pressure surge evaluated by information and communication technology–based nocturnal home blood pressure monitoring
  af: Fujiwara, Takeshi, et al.
  Udgivet: (2018)
• Comparison of morning vs bedtime administration of the combination of valsartan/amlodipine on nocturnal brachial and central blood pressure in patients with hypertension
  af: Fujiwara, Takeshi, et al.
  Udgivet: (2017)